Canopy Growth (CGC) Profit After Tax (2019 - 2026)
Canopy Growth (CGC) posted Profit After Tax of -$77.6 million for Q4 2025, down 2044.68% sequentially from -$3.6 million in Q3 2025, and down 10.49% YoY from -$86.7 million in Q4 2024.
Canopy Growth (CGC) Profit After Tax (2019 - 2026) Analysis & Trends
Canopy Growth has reported Profit After Tax for 7 years, with the latest figure at -$77.6 million in Q4 2025.
- Quarterly Profit After Tax fell 10.49% year-over-year to -$77.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$183.8 million (up 7.65% YoY) and the FY2026 annual result came in at -$191.7 million, up 46.57% from the prior year.
- Profit After Tax slipped to -$77.6 million in Q4 2025 per CGC's latest filing, from -$3.6 million in the prior quarter.
- Over five years, Profit After Tax peaked at $319.2 million in Q2 2021 and troughed at -$1.6 billion in Q2 2022.
- A 5-year average of -$206.5 million and a median of -$82.3 million in 2024 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2021 and 2022: Profit After Tax surged 507.97% in 2021, then tumbled 2569.22% in 2022.
- Over 5 years, Profit After Tax stood at -$91.6 million in 2021, then sank by 92.97% to -$176.8 million in 2022, then increased by 14.56% to -$151.1 million in 2023, then jumped by 53.52% to -$70.2 million in 2024, then fell by 10.49% to -$77.6 million in 2025.
- According to Business Quant data, Profit After Tax over the past three periods registered -$77.6 million, -$3.6 million, and -$32.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Canopy Growth | 432.82 Mn | 185.81 Mn | 16.08 Mn | -10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.54 Mn |
| Dec 31, 2025 | -77.58 Mn |
| Sep 30, 2025 | -3.62 Mn |
| Jun 30, 2025 | -32.38 Mn |
| Dec 31, 2024 | -70.21 Mn |
| Sep 30, 2024 | -82.26 Mn |
| Jun 30, 2024 | -78.91 Mn |
| Mar 31, 2024 | 32.37 Mn |
| Dec 31, 2023 | -151.07 Mn |
| Sep 30, 2023 | -224.82 Mn |
| Jun 30, 2023 | -28.38 Mn |
| Mar 31, 2023 | -479.03 Mn |
| Dec 31, 2022 | -176.81 Mn |
| Sep 30, 2022 | -234.48 Mn |
| Jun 30, 2022 | -1.64 Bn |
| Mar 31, 2022 | -408.19 Mn |
| Dec 31, 2021 | -91.63 Mn |
| Sep 30, 2021 | -8.78 Mn |
| Jun 30, 2021 | 319.24 Mn |
| Mar 31, 2021 | -487.25 Mn |